Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again? ; volume:13 ; number:1 ; day:12 ; month:6 ; year:2021 ; pages:1-5 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (12.6.2021), 1-5, 12.2021

Urheber
Xiong, Nian
Schiller, Martin R.
Li, Jingwen
Chen, Xiaowu
Lin, Zhicheng
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13195-021-00858-9
URN
urn:nbn:de:101:1-2021100321275384060657
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:28 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Xiong, Nian
  • Schiller, Martin R.
  • Li, Jingwen
  • Chen, Xiaowu
  • Lin, Zhicheng
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis

Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis

Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease

Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease

Alzheimer’s Disease

Alzheimer’s Disease

Nutritional management for Alzheimer’s disease in all stages: mild, moderate, and severe

Nutritional management for Alzheimer’s disease in all stages: mild, moderate, and severe

Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease

Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease

Molecular cross-talk between long COVID-19 and Alzheimer’s disease

Molecular cross-talk between long COVID-19 and Alzheimer’s disease

Alzheimer

Alzheimer

Alzheimer

Alzheimer

The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms

The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms

COVID-19 and Alzheimer’s disease: how one crisis worsens the other

COVID-19 and Alzheimer’s disease: how one crisis worsens the other

Generalvollmacht: Eduard Alzheimer für Karl Alzheimer

Archivale

Generalvollmacht: Eduard Alzheimer für Karl Alzheimer

Treatments in Alzheimer’s disease

Treatments in Alzheimer’s disease

Verbundene Objekte